Aspirin’s effects on CRCs with the PIK3CA mutation are a hot research topic [ 48 ], with results from an RCT that examined disease-free survival in CRC patients diagnosed at stages II–III, finding a clear trend towards improved survival in aspirin users [ 49 ].
← all excerpts
Chemoprevention of Colorectal Cancer-With Emphasis on Low-Dose Aspirin and Anticoagulants.
1
—
—